Group items tagged

Ontario announced a new fund to attract and retain world-leading genomics researchers in the province.The $100-million Global Leadership Round in Genomics and Life Sciences will support globally-significant, collaborative research projects that are headquartered in Ontario. Dr. Evans is quoted stating that "the government must recognize that Ontario must invest in strong life science clusters."

Ontario announced a new fund to attract and retain world-leading genomics researchers in the province.The $100-million Global Leadership Round in Genomics and Life Sciences will support globally-significant, collaborative research projects that are headquartered in Ontario. Dr. Evans is quoted stating that "the government must recognize that Ontario must invest in strong life science clusters."

The Ontario Genomics Institute (OGI) teamed up with Invitrogen Corporation, a California-based global leader in providing life sciences technology, recently to host Genome 2.0: New Frontiers in Epigenomics, a one-day symposium addressing epigenetic regulation of gene expression with a special focus on chromatin biology, DNA methylation, non-coding RNAs and technology development.

Calvin Stiller, chairman of the Ontario Institute for Cancer Research, won the Canada Gairdner Wightman Award for his work on the use of cyclosporine as a treatment for organ transplant rejection, but also for his role as a scientific entrepreneur, and a rainmaker for major scientific projects. Dr. Calvin Stiller is the Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada.

As stated by Alastair Harris-Cartwright "Dr. Andrei Yudin, Professor, Department of Chemistry, University of Toronto, has developed a new and effective process that makes linear peptides circular, which allows these molecules, called macrocycles, to enter cells more effectively and increase their stability compared to linear peptides." The Ontario Genomics Institute (OGI) a MaRS Tenant has invested in this project. The project is also supported by MaRS Innovation that is assisting to convert this "great science into commercial opportunities."

The 2010 Canada Gairdner Awards honour groundbreaking medical research behind cancer, epilepsy and heart disease and malaria treatments. Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.

MD-entrepreneur Cal Stiller, noted for advocating commercial development of research, wins Gairdner Award and hall of fame berth. Dr. Calvin Stiller is the Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada.

The 2010 Canada Gairdner Awards honour groundbreaking medical research behind cancer, epilepsy and heart disease and malaria treatments. Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.

Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.

The Ontario Genomics Institute has given funding to MaRS life sciences client, ArcticDX. They'll use the money for studies in preparation for a Food and Drug Administration approval for their product. The funding comes through its Pre-Commercialization Business Development Fund (PBDF)

Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.